Protocol for Desensitization to Atezolizumab and Bevacizumab After Severe Anaphylaxis in the Treatment of Lung Adenocarcinoma
SN González-Díaz, RV Villarreal-González, CE De Lira- Quezada, GK Rocha-Silva, Víctor Manuel Oyervides-Juárez, Óscar Vidal-Gutiérrez
Topics & Concepts
MedicineAtezolizumabAnaphylaxisDesensitization (medicine)BevacizumabAdenocarcinomaLungInternal medicineOncologyImmunotherapyPembrolizumabImmunologyAllergyChemotherapyCancerReceptorDrug-Induced Adverse ReactionsUrticaria and Related ConditionsFood Allergy and Anaphylaxis Research